- Work address
-
C. Heymanslaan 10, ingang 22 - verdieping 2
9000 Gent - Stijn.DeMunter@UGent.be
- ORCID iD
-
0000-0003-3821-0620
Show
Sort by
-
- Journal Article
- A1
- open access
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials
-
- Journal Article
- A1
- open access
In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality
-
- Journal Article
- A1
- open access
Photothermal nanofibres enable safe engineering of therapeutic cells
-
- Journal Article
- A1
- open access
Human thymic CD10+ PD-1+ intraepithelial lymphocyte precursors acquire interleukin-15 responsiveness at the CD1a– CD95+ CD28– CCR7– developmental stage
-
- Journal Article
- A1
- open access
Intracellular delivery of mRNA in adherent and suspension cells by vapor nanobubble photoporation
-
- Journal Article
- A1
- open access
Rapid and effective generation of nanobody based CARs using PCR and Gibson Assembly
-
- Journal Article
- A1
- open access
T-cells with a single tumor antigen-specific T-cell receptor can be generated in vitro from clinically relevant stem cell sources
-
- Journal Article
- A1
- open access
Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies
-
- Journal Article
- A1
- open access
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
-
- Conference Paper
- C3
- open access
TARP as immunotherapeutic target in AML expressed in the LSC compartment